Company Filing History:
1 out of 243 
1 out of 2,575 
Years Active: 2018
Title: Yingtao Bi: Innovator in Glioblastoma Diagnosis
Introduction
Yingtao Bi is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of medical diagnostics. His work primarily focuses on the diagnosis of glioblastoma, a highly aggressive brain tumor. With one patent to his name, Bi's innovations are paving the way for more accurate and efficient diagnostic methods.
Latest Patents
Yingtao Bi's patent, titled "Methods and compositions for diagnosis of glioblastoma or a subtype thereof," introduces an isoform-level gene panel that can accurately classify glioblastoma subtypes from tumor samples. This gene panel comprises 121 to 214 target isoforms, as identified in his research. The patent also details reagents for quantitatively detecting the expression or activity of these target isoforms in patient samples. Such reagents can include PCR primer and probe sets. The isoform-level gene panel and detection reagents are instrumental in conducting isoform-level assays for diagnosing the molecular subtype of glioblastoma in patients. The assay utilizes algorithms and a novel computer program to enhance diagnostic accuracy, and it is designed to operate in a high-throughput format.
Career Highlights
Throughout his career, Yingtao Bi has worked with prestigious institutions, including The Wistar Institute of Anatomy & Biology and the University of Pennsylvania. His experience in these research environments has allowed him to develop innovative solutions for complex medical challenges.
Collaborations
Yingtao Bi has collaborated with esteemed colleagues such as Ramana V Davuluri and Sharmistha Pal. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Yingtao Bi's contributions to glioblastoma diagnosis exemplify the impact of innovative thinking in the medical field. His patented methods and compositions are set to enhance diagnostic accuracy and improve patient outcomes.